Cellectis (CLLS) Misses Q1 EPS Views

Cellectis (NASDAQ: CLLS) reported Q1 EPS of (EUR0.84), EUR0.44 worse than the analyst estimate of (EUR0.40). Revenue for the quarter came in at EUR9.5 million versus the consensus estimate of EUR10.3 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• SpaceX: New Street Research sees 22% upside from proposed IPO price
• These 2 things are key for Meta stock re-rating: BofA
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance